World Health Organization Sounds Alert Over Acute Lack of Obesity Medications

Less than a tenth of people who could benefit from weight-loss injections including Wegovy can access them, states the global health agency as it publishes its first advice on the drugs.

Given in excess of 1,000,000,000 individuals worldwide now living with obesity, it is urging increased and just availability to this class of drugs.

Based on projections, over two billion are projected to be obese by 2030 without intervention.

"Our new guidelines acknowledges that excess weight is a lifelong illness that can be managed with thorough and lifelong treatment," stated its chief Tedros Adhanom Ghebreyesus.

High costs, constrained manufacturing, and distribution challenges are major obstacles to widespread availability to the jabs that can aid individuals in losing substantial body mass, explains the agency.

Skinny Jab Scarcity

Despite the current best projected case, the manufacturing of these medications might only reach approximately 100 million people – less than 10% of eligible patients, according to the WHO.

The guideline encourages nations and manufacturers to increase availability, via approaches such as voluntary licensing.

The intellectual property rights on the active ingredient – the core component of a leading brand – is due to expire in multiple nations in 2026.

How Weight-Loss Drugs Work

These medications mimick a body's own hormone to reduce digestion speed, suppress the appetite and boost satiety so users eat less.

People commonly start to lose weight in the initial weeks of commencing the weekly injections.

Studies suggests people may regain a significant portion after a year of discontinuing the treatment, as their usual food cravings resume.

To be above a healthy weight raises your risk for developing diseases, like diabetes, cardiovascular issues, brain attack, and specific malignancies.

Obesity impacts individuals in every country and was associated with millions of fatalities worldwide in 2024, as per the WHO.